Research study Program year 2021 Source: CMS Open Payments

An Open-Label, Single-Arm Multicenter Phase 1b/2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Subjects With Metastatic Triple-Negative Breast Cancer (mTNBC)

Research payments

$4,218,309

2,394 payments

Through program year 2021, $4,218,309 in research payments was reported against An Open-Label, Single-Arm Multicenter Phase 1b/2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Subjects With Metastatic Triple-Negative Breast Cancer (mTNBC), across 2,394 payments, paid by Eisai Inc..

Paid by: Eisai Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$653,997	115
2020	Research	$256,324	282
2019	Research	$3,307,989	1,997

Breakdown

Who paid Research payments · program years 2019–2021

Eisai Inc. $4,218,309 2,394 payments

Who received the money Research payments · program years 2019–2021

Florida Cancer Affiliates Organisation paid for research $1,422,799 752 payments
Trustees of Columbia University Organisation paid for research $433,612 140 payments
Board Of Regents Of The University Of Wisconsin System Organisation paid for research $349,695 224 payments
Dana-Farber Cancer Institute Teaching hospital · MA $339,343 169 payments
Washington University Organisation paid for research $210,175 115 payments
South Carolina Oncology Associates Organisation paid for research $198,149 170 payments
University of Texas Health Science Center at San Antonio Organisation paid for research $166,301 150 payments
Dana Farber Partners Cancer Care Organisation paid for research $163,119 39 payments
Trustees Of Columbia University In The City Of New York Organisation paid for research $154,883 24 payments
Minnesota Oncology Organisation paid for research $106,874 118 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.